Drug Repurposing Market Report

Global Drug Repurposing Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 12, 2022
  • PAGES：156
  • REPORT CODE：GMM814471
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Drug Repurposing market report explains the definition, types, applications, major countries, and major players of the Drug Repurposing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Allergan

    • Astellas Pharma

    • AbbVie

    • Pfizer

    • Biovista

    • Novartis

    • NuMedii

    By Type:

    • Oncology

    • CNS Diseases

    • Neurodegenerative Diseases

    • Others

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Drug Repurposing Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Drug Repurposing Outlook to 2028- Original Forecasts

    • 2.2 Drug Repurposing Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Drug Repurposing Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Drug Repurposing Market- Recent Developments

    • 6.1 Drug Repurposing Market News and Developments

    • 6.2 Drug Repurposing Market Deals Landscape

    7 Drug Repurposing Raw Materials and Cost Structure Analysis

    • 7.1 Drug Repurposing Key Raw Materials

    • 7.2 Drug Repurposing Price Trend of Key Raw Materials

    • 7.3 Drug Repurposing Key Suppliers of Raw Materials

    • 7.4 Drug Repurposing Market Concentration Rate of Raw Materials

    • 7.5 Drug Repurposing Cost Structure Analysis

      • 7.5.1 Drug Repurposing Raw Materials Analysis

      • 7.5.2 Drug Repurposing Labor Cost Analysis

      • 7.5.3 Drug Repurposing Manufacturing Expenses Analysis

    8 Global Drug Repurposing Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Drug Repurposing Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Drug Repurposing Export by Region (Top 10 Countries) (2017-2028)

    9 Global Drug Repurposing Market Outlook by Types and Applications to 2022

    • 9.1 Global Drug Repurposing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CNS Diseases Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Neurodegenerative Diseases Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Drug Repurposing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Drug Repurposing Market Analysis and Outlook till 2022

    • 10.1 Global Drug Repurposing Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Drug Repurposing Consumption (2017-2022)

      • 10.2.2 Canada Drug Repurposing Consumption (2017-2022)

      • 10.2.3 Mexico Drug Repurposing Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Drug Repurposing Consumption (2017-2022)

      • 10.3.2 UK Drug Repurposing Consumption (2017-2022)

      • 10.3.3 Spain Drug Repurposing Consumption (2017-2022)

      • 10.3.4 Belgium Drug Repurposing Consumption (2017-2022)

      • 10.3.5 France Drug Repurposing Consumption (2017-2022)

      • 10.3.6 Italy Drug Repurposing Consumption (2017-2022)

      • 10.3.7 Denmark Drug Repurposing Consumption (2017-2022)

      • 10.3.8 Finland Drug Repurposing Consumption (2017-2022)

      • 10.3.9 Norway Drug Repurposing Consumption (2017-2022)

      • 10.3.10 Sweden Drug Repurposing Consumption (2017-2022)

      • 10.3.11 Poland Drug Repurposing Consumption (2017-2022)

      • 10.3.12 Russia Drug Repurposing Consumption (2017-2022)

      • 10.3.13 Turkey Drug Repurposing Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Drug Repurposing Consumption (2017-2022)

      • 10.4.2 Japan Drug Repurposing Consumption (2017-2022)

      • 10.4.3 India Drug Repurposing Consumption (2017-2022)

      • 10.4.4 South Korea Drug Repurposing Consumption (2017-2022)

      • 10.4.5 Pakistan Drug Repurposing Consumption (2017-2022)

      • 10.4.6 Bangladesh Drug Repurposing Consumption (2017-2022)

      • 10.4.7 Indonesia Drug Repurposing Consumption (2017-2022)

      • 10.4.8 Thailand Drug Repurposing Consumption (2017-2022)

      • 10.4.9 Singapore Drug Repurposing Consumption (2017-2022)

      • 10.4.10 Malaysia Drug Repurposing Consumption (2017-2022)

      • 10.4.11 Philippines Drug Repurposing Consumption (2017-2022)

      • 10.4.12 Vietnam Drug Repurposing Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Drug Repurposing Consumption (2017-2022)

      • 10.5.2 Colombia Drug Repurposing Consumption (2017-2022)

      • 10.5.3 Chile Drug Repurposing Consumption (2017-2022)

      • 10.5.4 Argentina Drug Repurposing Consumption (2017-2022)

      • 10.5.5 Venezuela Drug Repurposing Consumption (2017-2022)

      • 10.5.6 Peru Drug Repurposing Consumption (2017-2022)

      • 10.5.7 Puerto Rico Drug Repurposing Consumption (2017-2022)

      • 10.5.8 Ecuador Drug Repurposing Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Drug Repurposing Consumption (2017-2022)

      • 10.6.2 Kuwait Drug Repurposing Consumption (2017-2022)

      • 10.6.3 Oman Drug Repurposing Consumption (2017-2022)

      • 10.6.4 Qatar Drug Repurposing Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Drug Repurposing Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Drug Repurposing Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Drug Repurposing Consumption (2017-2022)

      • 10.7.2 South Africa Drug Repurposing Consumption (2017-2022)

      • 10.7.3 Egypt Drug Repurposing Consumption (2017-2022)

      • 10.7.4 Algeria Drug Repurposing Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Drug Repurposing Consumption (2017-2022)

      • 10.8.2 New Zealand Drug Repurposing Consumption (2017-2022)

    11 Global Drug Repurposing Competitive Analysis

    • 11.1 Allergan

      • 11.1.1 Allergan Company Details

      • 11.1.2 Allergan Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Allergan Drug Repurposing Main Business and Markets Served

      • 11.1.4 Allergan Drug Repurposing Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Astellas Pharma

      • 11.2.1 Astellas Pharma Company Details

      • 11.2.2 Astellas Pharma Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Astellas Pharma Drug Repurposing Main Business and Markets Served

      • 11.2.4 Astellas Pharma Drug Repurposing Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 AbbVie

      • 11.3.1 AbbVie Company Details

      • 11.3.2 AbbVie Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 AbbVie Drug Repurposing Main Business and Markets Served

      • 11.3.4 AbbVie Drug Repurposing Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Pfizer

      • 11.4.1 Pfizer Company Details

      • 11.4.2 Pfizer Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Pfizer Drug Repurposing Main Business and Markets Served

      • 11.4.4 Pfizer Drug Repurposing Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Biovista

      • 11.5.1 Biovista Company Details

      • 11.5.2 Biovista Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Biovista Drug Repurposing Main Business and Markets Served

      • 11.5.4 Biovista Drug Repurposing Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Novartis

      • 11.6.1 Novartis Company Details

      • 11.6.2 Novartis Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Novartis Drug Repurposing Main Business and Markets Served

      • 11.6.4 Novartis Drug Repurposing Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 NuMedii

      • 11.7.1 NuMedii Company Details

      • 11.7.2 NuMedii Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 NuMedii Drug Repurposing Main Business and Markets Served

      • 11.7.4 NuMedii Drug Repurposing Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Drug Repurposing Market Outlook by Types and Applications to 2028

    • 12.1 Global Drug Repurposing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global CNS Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Neurodegenerative Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Drug Repurposing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Drug Repurposing Market Analysis and Outlook to 2028

    • 13.1 Global Drug Repurposing Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Drug Repurposing Consumption Forecast (2022-2028)

      • 13.2.2 Canada Drug Repurposing Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Drug Repurposing Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.2 UK Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.3 Spain Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.5 France Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.6 Italy Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.8 Finland Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.9 Norway Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.11 Poland Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.12 Russia Drug Repurposing Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Drug Repurposing Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.2 Japan Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.3 India Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Drug Repurposing Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Drug Repurposing Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Drug Repurposing Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Drug Repurposing Consumption Forecast (2022-2028)

      • 13.5.3 Chile Drug Repurposing Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Drug Repurposing Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Drug Repurposing Consumption Forecast (2022-2028)

      • 13.5.6 Peru Drug Repurposing Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Drug Repurposing Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Drug Repurposing Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Drug Repurposing Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Drug Repurposing Consumption Forecast (2022-2028)

      • 13.6.3 Oman Drug Repurposing Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Drug Repurposing Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Drug Repurposing Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Drug Repurposing Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Drug Repurposing Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Drug Repurposing Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Drug Repurposing Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Drug Repurposing Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Drug Repurposing Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Drug Repurposing Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Drug Repurposing

    • Figure of Drug Repurposing Picture

    • Table Global Drug Repurposing Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Drug Repurposing Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global CNS Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Neurodegenerative Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Repurposing Consumption by Country (2017-2022)

    • Table North America Drug Repurposing Consumption by Country (2017-2022)

    • Figure United States Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Canada Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Mexico Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Table Europe Drug Repurposing Consumption by Country (2017-2022)

    • Figure Germany Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure UK Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Spain Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Belgium Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure France Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Italy Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Denmark Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Finland Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Norway Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Sweden Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Poland Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Russia Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Turkey Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Table APAC Drug Repurposing Consumption by Country (2017-2022)

    • Figure China Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Japan Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure India Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Thailand Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Singapore Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Philippines Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Table South America Drug Repurposing Consumption by Country (2017-2022)

    • Figure Brazil Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Colombia Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Chile Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Argentina Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Peru Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Table GCC Drug Repurposing Consumption by Country (2017-2022)

    • Figure Bahrain Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Oman Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Qatar Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Table Africa Drug Repurposing Consumption by Country (2017-2022)

    • Figure Nigeria Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure South Africa Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Egypt Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure Algeria Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Table Oceania Drug Repurposing Consumption by Country (2017-2022)

    • Figure Australia Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Drug Repurposing Consumption and Growth Rate (2017-2022)

    • Table Allergan Company Details

    • Table Allergan Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Drug Repurposing Main Business and Markets Served

    • Table Allergan Drug Repurposing Product Portfolio

    • Table Astellas Pharma Company Details

    • Table Astellas Pharma Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Drug Repurposing Main Business and Markets Served

    • Table Astellas Pharma Drug Repurposing Product Portfolio

    • Table AbbVie Company Details

    • Table AbbVie Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Drug Repurposing Main Business and Markets Served

    • Table AbbVie Drug Repurposing Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Drug Repurposing Main Business and Markets Served

    • Table Pfizer Drug Repurposing Product Portfolio

    • Table Biovista Company Details

    • Table Biovista Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biovista Drug Repurposing Main Business and Markets Served

    • Table Biovista Drug Repurposing Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Drug Repurposing Main Business and Markets Served

    • Table Novartis Drug Repurposing Product Portfolio

    • Table NuMedii Company Details

    • Table NuMedii Drug Repurposing Sales, Price, Value and Gross Profit (2017-2022)

    • Table NuMedii Drug Repurposing Main Business and Markets Served

    • Table NuMedii Drug Repurposing Product Portfolio

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CNS Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurodegenerative Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Repurposing Consumption Forecast by Country (2022-2028)

    • Table North America Drug Repurposing Consumption Forecast by Country (2022-2028)

    • Figure United States Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Drug Repurposing Consumption Forecast by Country (2022-2028)

    • Figure Germany Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Drug Repurposing Consumption Forecast by Country (2022-2028)

    • Figure China Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Drug Repurposing Consumption Forecast by Country (2022-2028)

    • Figure Brazil Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Drug Repurposing Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Drug Repurposing Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Drug Repurposing Consumption Forecast by Country (2022-2028)

    • Figure Australia Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Drug Repurposing Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US